Article Information
History
- September 9, 2018.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aleksejs Sazonovs1,
- Nick Kennedy2,
- Loukas Moutsianas1,
- Graham A. Heap2,
- Daniel L. Rice1,
- Mark Reppell3,
- Claire Bewshea2,
- Gareth Walker2,
- Mandy H. Perry4,
- Timothy J. McDonald4,
- Charlie Lees5,
- Fraser Cummings6,
- Miles Parkes7,
- John Mansfield8,
- Jeffrey C. Barrett1,
- Dermot McGovern9,
- James Goodhand2,
- Carl A. Anderson1,*,
- Tariq Ahmad2,*,
- PANTS consortium
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
- 2Exeter IBD and Pharmacogenetics Research Group, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
- 3AbbVie Inc. North Chicago, Illinois, USA
- 4Exeter Blood Sciences Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
- 5Gastrointestinal Unit, Western General Hospital University of Edinburgh, Edinburgh, UK
- 6Department of Gastroenterology, Southampton General Hospital, Southampton, UK
- 7Inflammatory Bowel Disease Research Group, Addenbrooke’s Hospital, Cambridge, UK
- 8The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK
- 9F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, USA
- ↵*Corresponding authors: Dr Carl A. Anderson ca3{at}sanger.ac.uk; Dr Tariq Ahmad tariq.ahmad1{at}nhs.net